Objectives {7}
SECONDARY
Our clinical trial aims to determine whether community-based ART initiation and maintenance increase the proportion of ART-eligible persons living with HIV who achieve viral suppression at 18 months. We will also evaluate as secondary objectives the (1) qualitative preferences of clients and providers for differentiated service delivery intensification and (2) cost, budget impact, and cost-effectiveness of an adaptative HIV treatment strategy for persons living with HIV who are not engaged in care to support viral suppression.